← Evidence map

ArticleCurrent oncology (Toronto, Ont.)2020

Nivolumab in metastatic melanoma: good efficacy and tolerability in elderly patients.

R De Luca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32489255